TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A MedPage Today report published Oct. 8 describes two patients who received insurance approval after escalating disputes to company leaders. The cases suggest that executive outreach can draw attention to denials, but they do not show how often the approach works or establish it as a reliable appeals route.
Two patients whose care was initially denied or treated as out of network received insurance approval after contacting company executives, according to a MedPage Today report published Oct. 8. The cases, highlighted by former insurance executive Wendell Potter, show how taking a dispute to a CEO’s office may prompt review, but do not establish how often the tactic succeeds.
One case involved Elizabeth Nicholas, who was diagnosed with breast cancer at age 36. After months of treatment, her insurer declined to cover the chemotherapy her oncologist recommended. Nicholas emailed the company’s CEO, and she soon received a message from its chief scientific officer saying the treatment had been approved. Nicholas had also written about her experience in Vanity Fair the previous month, and Potter told MedPage Today the case had been brokered by a journalist.
The other patient, Donald E. Grant Jr., was 49 and had severe congenital cervical stenosis. After an earlier artificial disc replacement did not adequately decompress his spinal cord, he developed myelomalacia, according to the report. Grant had surgery scheduled with Cedars-Sinai spine surgeon Hyun Bae, but Bae was out of network even though the other components of the operation were covered.
Grant used Claimable, an AI-assisted appeal platform, to help prepare an 11-page medical and legal appeal. It argued that his insurer had no in-network surgeon with comparable qualifications, cited regulations and asked that algorithms not be used to decide his case. He sent the appeal to UnitedHealth Group’s CEO and copied other company leaders, legislators and journalists. UnitedHealthcare approved the procedure at the in-network rate, MedPage Today reported.
Executive Appeals Can Draw Attention
The cases matter to patients facing costly or time-sensitive disputes because they describe a route beyond conventional appeal channels: bringing the issue to senior executives and, in Grant’s case, involving legislators and journalists. Potter, who previously worked at Cigna, said cases receiving media attention or elevated to senior leadership can receive special handling. That is his account of industry practice, not evidence that executive emails lead to approval in most disputes.
The examples also show how much work may sit behind an escalation. Grant assembled a detailed appeal addressing medical qualifications and insurance rules; Nicholas’s dispute was also covered by a journalist. Neither case suggests that simply emailing a CEO guarantees coverage, or that patients can avoid the ordinary appeal process. For people without time, expertise or outside support, the tactic may be harder to use.
Potter warned that escalation can carry risks for clinicians who repeatedly challenge insurers. He said a doctor who becomes a frequent critic could irritate a company and potentially be removed from its network. The report does not document that happening to either patient or provider in these cases, but the warning underscores that raising disputes may have consequences beyond a single claim.
AI-assisted medical appeal platform
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Two Cases Behind the Report
MedPage Today’s story drew on examples discussed by Wendell Potter in his Substack newsletter, Health Care Un-Covered. Potter told the publication that, during his time at Cigna, cases being investigated by reporters were elevated. He described large insurers as having staff around the CEO who handle high-profile disputes referred to senior leadership or public relations.
The two examples differ in how they reached a resolution. Nicholas’s experience had been reported in Vanity Fair, while Grant built a lengthy appeal and copied multiple audiences when contacting UnitedHealth Group’s leadership. Both ultimately received approval, but the article provides no comparison with similar cases that did not escalate, and no data on the frequency or outcomes of CEO-directed appeals.
Healthcare policy advocate Eagan Kemp of Public Citizen told MedPage Today that patients and providers should not have to spend so much time securing approval for medically necessary care or track down executives to do so. Kemp connected frustration with insurance intermediaries to growing interest in Medicare for All; that is his policy view, not a finding established by the two patient stories.
“You can be certain that at big insurance companies, there is a group of people around the CEO who are dedicated to high-profile cases and cases that are elevated to the C-suite or to the PR department — and they get special attention.”
— Wendell Potter, former insurance company executive, to MedPage Today
As an affiliate, we earn on qualifying purchases.
How Often Escalation Works
The report describes two successful cases, not a study of patient appeals. It gives no success rate, insurer-wide data or information about how many comparable emails fail to change a decision. It is also unclear whether the outcomes depended on the executive outreach itself, the detail of the appeals, media attention, or a combination of factors.
The article does not provide the insurers’ full explanations for the original decisions, the precise timeline for either review, or the terms and limits of the approvals beyond the details reported. It also does not establish that the cases represent typical disputes or explain whether patients who try this approach face different outcomes from those who use formal appeals alone.
As an affiliate, we earn on qualifying purchases.
Formal Appeals Remain Relevant
The source report does not identify a pending policy change or a scheduled next step for either patient. For people with denied claims, the immediate question remains whether an insurer will review an appeal and what documentation it requires; the article’s cases show executive outreach as an additional tactic, not a replacement for established review routes.
Potter urged patients and clinicians not to treat an initial denial as necessarily final and said doctors may increasingly bring disputes to senior company leadership. Kemp’s comments point to a wider policy debate about the burden of obtaining care approvals. Whether more patients adopt CEO-directed appeals, and whether insurers change how they handle such requests, remains unclear.
health insurance claim review tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What happened in the two cases?
Elizabeth Nicholas received approval for recommended chemotherapy after emailing her insurer’s CEO. Donald E. Grant Jr. received approval for an operation with an out-of-network surgeon at the in-network rate after sending a detailed appeal to UnitedHealth Group’s CEO and others.
Does emailing an insurance CEO guarantee approval?
No. The report presents two successful examples and gives no data showing how often executive escalation works. It cannot establish that an email will change another insurer’s decision.
What was unusual about Grant’s appeal?
Grant used Claimable, an AI-assisted appeal platform, to help prepare an 11-page submission. It argued that no in-network surgeon had comparable qualifications, cited regulations and requested that algorithms not be used to determine the case.
What risks did the report mention?
Potter warned that insurers might react negatively to clinicians who repeatedly challenge decisions and said a doctor could potentially be removed from a network. The report does not say that happened in either case.
What remains unknown about the strategy?
The report does not provide a success rate or broader insurer data. It is unclear how much the outcomes depended on executive contact, detailed appeals, media attention or other factors.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
